Gudui Biopharma Technology Inc.

China

Back to Profile

1-7 of 7 for Gudui Biopharma Technology Inc. Sort by
Query
Aggregations
Date
2020 1
Before 2020 6
IPC Class
A61P 35/00 - Antineoplastic agents 6
A61K 31/7135 - Compounds containing heavy metals 4
C07H 1/00 - Processes for the preparation of sugar derivatives 3
C07H 23/00 - Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12 3
C07F 15/00 - Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table 2
See more
Found results for  patents

1.

SUBSTITUTED PYRAZOLE COMPOUND, AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND USE THEREOF

      
Application Number CN2019100835
Publication Number 2020/038279
Status In Force
Filing Date 2019-08-15
Publication Date 2020-02-27
Owner GUDUI BIOPHARMA TECHNOLOGY INC. (China)
Inventor
  • Han, Jianbin
  • Wen, Xiang
  • Li, Zedong
  • Yang, Jinna
  • Yang, Liu

Abstract

A substituted pyrazole compound represented by formula I, and a preparation method, a pharmaceutical composition, and use thereof. The compound has good stability, excellent solubility, small cell toxicity, and a significant effect on neuroprotection, can effectively prevent and treat nerve cell damages, and is an ideal pharmaceutical compound for preventing or treating cerebral apoplexy, cerebral embolism, cerebral apoplexy sequelae, cerebral apoplexy motion dysfunction, mitochondria brain myopathy, and amyotrophic lateral sclerosis. (I)

IPC Classes  ?

  • C07D 231/22 - One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
  • C07H 17/02 - Heterocyclic radicals containing only nitrogen as ring hetero atoms
  • A61K 31/4152 - 1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
  • A61K 31/7056 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
  • A61P 9/10 - Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

2.

CYCLOBUTANE DICARBOXYLIC ACID PLATINUM COMPLEX AND INTERMEDIARY, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND USE THEREOF

      
Application Number CN2019076236
Publication Number 2019/165964
Status In Force
Filing Date 2019-02-27
Publication Date 2019-09-06
Owner GUDUI BIOPHARMA TECHNOLOGY INC. (China)
Inventor
  • Gao, Xiangqian
  • Han, Jianbin
  • Yang, Jinna
  • Yang, Liu

Abstract

A cyclobutane dicarboxylic acid platinum complex shown in formula (I) and an intermediary, a preparation method, a pharmaceutical composition, and a use thereof. The cyclobutane dicarboxylic acid platinum complex has good anti-tumour activity. The complex provided in the present invention has a water solubility several dozen times higher than existing platinum anti-tumour drugs; the feature of high water solubility can increase and improve the excretion of drugs in the kidneys and alleviate the high renal toxicity side effects normally present for platinum drugs; the compounds are easily formulated and more convenient for clinical application.

IPC Classes  ?

  • C07F 15/00 - Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
  • A61K 31/282 - Platinum compounds
  • A61P 35/00 - Antineoplastic agents

3.

VITAMIN C-PLATINUM COMPLEX, INTERMEDIATE THEREOF, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE

      
Application Number CN2019084838
Publication Number 2019/166033
Status In Force
Filing Date 2019-04-28
Publication Date 2019-09-06
Owner GUDUI BIOPHARMA TECHNOLOGY INC. (China)
Inventor
  • Han, Jianbin
  • Gao, Xiangqian
  • Yang, Jinna
  • Yang, Liu

Abstract

A vitamin C-platinum complex as shown in formula (I), an intermediate thereof, a preparation method, a pharmaceutical composition and a use. The vitamin C-platinum complex has good anti-tumour activity. The complex of the present invention is dozens of times better than existing platinum-type anti-tumour drugs in terms of water solubility. The high water solubility can increase and improve drug excretion in the kidneys, and reduce the high renal toxic side effects which generally occur with platinum-type drugs. In addition, the compound is easy to formulate, and more convenient for clinical application.

IPC Classes  ?

  • C07F 15/00 - Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
  • A61P 35/00 - Antineoplastic agents

4.

WATER-SOLUBLE PLATINUM COORDINATION COMPLEX FOR TUMOUR TREATMENT AND PREPARATION METHOD THEREOF

      
Application Number CN2012077395
Publication Number 2012/175044
Status In Force
Filing Date 2012-06-22
Publication Date 2012-12-27
Owner GUDUI BIOPHARMA TECHNOLOGY INC. (China)
Inventor
  • Wang, Yiqiang
  • Liu, Yang

Abstract

Disclosed are a water-soluble platinum coordination complex for tumour treatment and a preparation method therefor, said coordination complex being shown as formula (I): The present platinum coordination complex shows a long-term antineoplastic effect superior to that of oxaliplatin, while the enhanced stability and solubility of the preparation favor its clinical use.

IPC Classes  ?

  • C07H 23/00 - Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
  • C07H 1/00 - Processes for the preparation of sugar derivatives
  • A61K 31/7135 - Compounds containing heavy metals
  • A61P 35/00 - Antineoplastic agents

5.

USE OF FLUORINE-CONTAINING, WATER-SOLUBLE PLATINUM COMPLEX IN PREPARING MEDICATIONS FOR PREVENTING AND TREATING TUMORS

      
Application Number CN2012077398
Publication Number 2012/175047
Status In Force
Filing Date 2012-06-22
Publication Date 2012-12-27
Owner GUDUI BIOPHARMA TECHNOLOGY INC. (China)
Inventor
  • Wang, Yiqiang
  • Liu, Yang

Abstract

Provided are a fluorine-containing, water-soluble platinum complex for treating tumors and a preparation method therefor. The complex is represented in formula (I). Experiments show that the complex of the present invention and medications prepared using the complex of the present invention have high water solubility and tumor target effects, and are convenient for clinical use.

IPC Classes  ?

6.

WATER-SOLUBLE FLUORINE-CONTAINING PLATINUM COORDINATION COMPLEX FOR TUMOUR TREATMENT AND PREPARATION METHOD THEREOF

      
Application Number CN2012077396
Publication Number 2012/175045
Status In Force
Filing Date 2012-06-22
Publication Date 2012-12-27
Owner GUDUI BIOPHARMA TECHNOLOGY INC. (China)
Inventor
  • Wang, Yiqiang
  • Liu, Yang

Abstract

Disclosed are a water-soluble fluorine-containing platinum coordination complex for tumour treatment and a preparation method therefor, said coordination complex being shown as formula (I): The present platinum coordination complex shows a long-term antineoplastic effect superior to that of oxaliplatin, while the enhanced stability and solubility of the preparation favor its clinical use.

IPC Classes  ?

  • C07H 23/00 - Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
  • C07H 1/00 - Processes for the preparation of sugar derivatives
  • A61K 31/7135 - Compounds containing heavy metals
  • A61P 35/00 - Antineoplastic agents

7.

USE OF WATER SOLUBLE PLATINUM COMPLEX IN PREPARING DRUGS FOR PREVENTION AND TREATMENT OF TUMOURS

      
Application Number CN2012077397
Publication Number 2012/175046
Status In Force
Filing Date 2012-06-22
Publication Date 2012-12-27
Owner GUDUI BIOPHARMA TECHNOLOGY INC. (China)
Inventor
  • Wang, Yiqiang
  • Liu, Yang

Abstract

Disclosed in the present invention is the use of a water soluble platinum coordination complex in preparing drugs for the prevention and treatment of tumours, said coordination complex being shown as formula (I). Experiments have demonstrated that the present platinum complex is able to prevent and treat cancer in mammals, and in particular, humans, said cancers including lung cancer, colorectal cancer, head and neck cancer, prostate cancer, mammary gland cancer, ovary cancer, cancer of the cervix, leukemia, lymphatic cancer, skin cancer, pancreatic gland cancer, liver cancer, bladder cancer, esophagus cancer, stomach cancer, male genital organ cancer, osteo-carcinoma and so on.

IPC Classes  ?

  • A61K 31/7135 - Compounds containing heavy metals
  • C07H 23/00 - Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
  • C07H 1/00 - Processes for the preparation of sugar derivatives
  • A61P 35/00 - Antineoplastic agents